Long-term treatment with subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: exploratory analysis of cumulative time and dose impact on clinical and magnetic resonance imaging outcomes

被引：0

|

作者：

Uitdehaag, B.

Kappos, L.

Verdun, E.

Gardner, J.

机构：

来源：

JOURNAL OF NEUROLOGY | 2009年 / 256卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S123 / S123

页数：1

相关论文

共 50 条

[1] Impact of cumulative dose and time on magnetic resonance imaging and clinical outcomes during long-term treatment with subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: exploratory analyses
Traboulsee, A.
Constantinescu, C.
Kappos, L.
Ll, D.
Sandberg, M.
Uitdehaag, B.
Gardner, J.
Verdun, E.
[J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S126 - S127
[2] Clinical and Magnetic Resonance Imaging Predictors of Long-Term Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis: Additional Analyses
Traboulsee, Anthony
Uitdehaag, Bernard M. J.
Kappos, Ludwig
Sandberg-Woilheim, Magnhild
Li, David
Jongen, Peter
Constantinescu, Cris
Verdun, Elisabetta
Cornelisse, Peter
[J]. NEUROLOGY, 2011, 76 (09) : A389 - A389
[3] Long-term benefits of early and high douses of interferon β-1a treatment in relapsing-remitting multiple sclerosis
Chofflon, M
Ben-Amor, AF
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) : 244 - 248
[4] Relation of long-term exposure to subcutaneous interferon-β-1a with clinical outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS-15 study
Kappos, L.
Cornelisse, P.
Lehr, L.
Kuhle, J.
Uitdehaag, B.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 39 - 39
[5] Long-term cost effectiveness of interferon-β-1a in the treatment of relapsing-remitting multiple sclerosis -: An econometric model
Lepen, C
Coyle, P
Vollmer, T
Blumhardt, L
Lilliu, H
Beresniak, A
[J]. CLINICAL DRUG INVESTIGATION, 2003, 23 (09) : 571 - 581
[6] Successful Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis with Interferon β-1b
Schmidt, S.
[J]. AKTUELLE NEUROLOGIE, 2012, 39 : S22 - S23
[7] Long-term adherence to interferon β therapy in relapsing-remitting multiple sclerosis
Portaccio, E.
Zipoli, V.
Siracusa, G.
Sorbi, S.
Amato, M. P.
[J]. EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 131 - 135
[8] A Post-Hoc Analysis of Cumulative Dose Effects of Subcutaneous Interferon Beta-la on Clinical and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis: Results over the Long Term
Jeffery, Douglas
Rivera, Victor M.
[J]. NEUROLOGY, 2009, 72 (11) : A237 - A237
[9] Spotlight on Subcutaneous Recombinant Interferon-β-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis
David Murdoch
Katherine A. Lyseng-Williamson
[J]. BioDrugs, 2005, 19 : 323 - 325
[10] Spotlight on subcutaneous recombinant interferon-β-1a (Rebif®) in relapsing-remitting multiple sclerosis
Murdoch, D
Lyseng-Williamson, KA
[J]. BIODRUGS, 2005, 19 (05) : 323 - 325

← 1 2 3 4 5 →